Dr. Julie Alyssa Lorber, MD

Dr. Lorber practices at Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System.

Dr. Lorber's NPI, 1225245947, was assigned on May 16, 2007. Dr. Lorber graduated from University of Toledo College of Medicine and Life Sciences in 2001. Dr. Lorber holds New Jersey license 25MA08251700.

Dr. Lorber's primary practice is Overlook Medical Center, at 99 Beauvoir Avenue, Summit, NJ 07901 in Union County. The practice phone is (908) 522-2000.

Dr. Lorber's primary practice is Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System. Dr. Lorber is also affiliated with Morristown Medical Center. Dmand AI also links Dr. Lorber to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lorber practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Lorber's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Lorber is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Lorber's licenses on file in 2 states: New Jersey and Florida.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Lorber treats.

CMS data shows 720 Medicare services from Dr. Lorber across 12 procedure codes in 2024, for 342 Medicare patients. Medicare paid $88,219 for them.

CMS counts 342 Medicare patients who saw Dr. Lorber in 2024. The largest group is 65 to 74, with 182 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lorber's median patient age at 58, with 70% women.

In 2024, Dr. Lorber wrote 275 Medicare Part D claims for 107 patients. 66% of them were for generic drugs. CMS names the drug for 115 of them, across 8 drugs with 11 or more claims each, at $21,462 in total drug cost. In 2023, CMS named 137 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 40 out of 100 for Dr. Lorber for performance year 2024, reported individually. Dr. Lorber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lorber as offering telehealth. CMS counts 187 procedures of colonoscopy by Dr. Lorber, more than 92% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Lorber. Dr. Lorber's most frequent co-author is Francis A. Farraye, MD.

CMS Open Payments shows 78 general payments to Dr. Lorber from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Bausch Health Americas, Inc. paid the most, $269.

Dmand AI lists 2 awards for Dr. Lorber.

Dr. Lorber graduated from University of Toledo College of Medicine and Life Sciences in 2001. Dr. Lorber is a member of ACS.

Dr. Lorber is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.